SCHEMBL1594972

SCHEMBL1594972

CS(=O)(=O)c1nnc(-c2ccc3cnsc3c2)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.38
PIM1 P11309 2/20 0.37
PIM3 Q86V86 2/20 0.37
PIM2 Q9P1W9 1/20 0.37
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
PI4KA P42356 2/20 0.34
PIK3CG P48736 2/20 0.34
PI4KB Q9UBF8 2/20 0.34
PIP5K1C O60331 1/20 0.34
PIK3CA P42336 2/20 0.33
TRPM5 Q9NZQ8 4/20 0.33
TRPA1 O75762 1/20 0.32
PTGS2 P35354 2/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
CA5A P35218 1/20 0.31
CA5B Q9Y2D0 1/20 0.31
SNCA P37840 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12727893 0.79 TRPM5 (0.46) TRPM5GSK3B
SCHEMBL1595231 0.76 CDK2 (0.42) THRBPIM1PIM3PIM2PIK3CD
SCHEMBL1595444 0.76 KDM4E (0.51) PIM1PIM3PIM2CSNK2A1
SCHEMBL1594532 0.75 PTGS1 (0.43) PIM1PIM3PIM2TRPM5TRPA1
SCHEMBL1594299 0.72 CSNK2A1 (0.43) PIM1PIM3CDC7PLK4AURKA
SCHEMBL17481700 0.71 ALDH1A1 (0.53) THRBPTGS2CA1CA2CA4
SCHEMBL9681615 0.70 KDM4E (0.51) THRBPTGS2CA1CA2CA5A
SCHEMBL7905128 0.70 CA1 (0.51) THRBPTGS2CA1CA2CA4
SCHEMBL1594969 0.69 KDM4E (0.44) CA1CA2CSNK2A1
SCHEMBL15854655 0.67 PIM1 (0.37) THRBPIM1PIM3PIM2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919504-B2 Thiadiazole modulators of PKB AMGEN INC. (US) 2011-04-05 US disclosed
US-7919504-B2 Thiadiazole modulators of PKB AMGEN INC. (US) 2011-04-05 US disclosed
EP-2167504-A2 THIADIAZOLE MODULATORS OF PKB Amgen, Inc (US) 2010-03-31 EP disclosed
US-20090298836-A1 Thiadiazole modulators of PKB AMGEN INC. (US) 2009-12-03 US disclosed
US-20090298836-A1 Thiadiazole modulators of PKB AMGEN INC. (US) 2009-12-03 US disclosed
WO-2009011871-A2 THIADIAZOLE MODULATORS OF PKB AMGEN INC. (US) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298836-A1 Thiadiazole modulators of PKB PDK1, PDK2, MTOR THRB 259/4885PIM1 112/4885PIM3 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.